Search

Your search keyword '"T. Lauritzen"' showing total 450 results

Search Constraints

Start Over You searched for: Author "T. Lauritzen" Remove constraint Author: "T. Lauritzen"
450 results on '"T. Lauritzen"'

Search Results

2. Atorvastatin lactone/acid ratios are promising biomarkers for statin dependent muscular side effects in patients with coronary heart disease

3. Clinical and pharmacological characteristics in plasma and mononuclear blood cells in patients with coronary heart disease and low statin tolerance

4. Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients

5. Patient and provider perceptions of care for diabetes: results of the cross-national DAWN Study

6. Alma-Ata to Berlin: diabetes prevention and treatment to achieve healthy living

7. Adaptive Volumetric Shadow Maps

8. Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes1

9. Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial

10. 3.3 ASSOCIATIONS BETWEEN PLASMA INCRETIN HORMONE RELEASE AND AORTIC STIFFNESS AND BLOOD PRESSURE IN INDIVIDUALS WITHOUT KNOWN DIABETES: THE ADDITION-PRO STUDY

11. The blood-retinal barrier permeability to fluorescein in juvenile diabetics treated with continuous subcutaneous insulin infusion

12. A desktop guide to Type 2 diabetes mellitus

13. A desktop guide to Type 1 (insulin-dependent) diabetes mellitus

14. Impact of moderate interval exercise versus supine rest on the pharmacokinetics and pharmacodynamic profiles of subcutaneously administered growth hormone in adult growth hormone deficient patients

15. The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status

16. Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen‐detected diabetes? Findings from the ADDITION‐Europe cluster‐randomized trial

17. Repeated screening for albumin-creatinine ratio in an unselected population

18. Screening for type 2 diabetes. Lessons from the ADDITION-Europe study

19. Sample distribution shadow maps

20. Pharmacokinetics and pharmacodynamics of different modes of insulin pump delivery. A randomized, controlled study comparing subcutaneous and intravenous administration of insulin aspart

21. Obesity does not influence the unique pharmacological properties of different biphasic insulin aspart preparations in patients with type 2 diabetes

25. Swelling Simulation Studies of Type 316 Stainless Steel

26. Microstructural Changes in Ion-Irradiated Commercial Alloys

27. Irradiation Embrittlement in Some Austenitic Superalloys

28. Void Swelling of Ferritic Alloys Bombarded with Nickel Ions

29. Microstructural Changes in Neutron-Irradiated Commercial Alloys: A Sequel

30. The Complex Action of Major Solutes on Radiation-Induced Swelling of Fe-Cr-Ni Austenitic Alloys

32. Spinodal-like Decomposition and Swelling Induced by Ion Irradiation in Simple Fe-Ni and Fe-Ni-Cr Alloys

33. Irradiation-Induced Swelling in AISI 316 Steel: Effect of Tensile and Compressive Stresses

34. Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes

35. The LBL 55-meter spherical grating monochromator at SSRL

36. High Resolution Results from the LBL 55-Meter SGM at SSRL Near the K-Edge of Carbon and Nitrogen

37. Are lifestyle changes achieved after participation in a screening programme for Type 2 diabetes? The ADDITION Study, Denmark

38. Short-term reproducibility of impaired fasting glycaemia, impaired glucose tolerance and diabetes The ADDITION study, DK

39. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes

40. Multiple mealtime administration of biphasic insulin aspart 30 versus traditional basal-bolus human insulin treatment in patients with type 1 diabetes

41. Variance shadow maps

42. Impact of insulin antibodies on insulin aspart pharmacokinetics and pharmacodynamics after 12-week treatment with multiple daily injections of biphasic insulin aspart 30 in patients with type 1 diabetes

43. Psychosocial problems and barriers to improved diabetes management:Results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study

44. Pharmacokinetic profiles of biphasic insulin aspart 30/70 and 70/30 in patients with Type 1 diabetes: a randomized double-blinded crossover study

45. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

46. Surveying the a monument system at Lawrence Berkeley Laboratory's Advanced Light Source accelerator

47. HbAlc in an unselected population of 4438 people with type 2 diabetes in a Danish county

48. A randomised controlled trial of screening for adult hearing loss during preventive health checks

49. [How do pharmacists evaluate the newly introduced system of substituting prescriptions?]

50. [How do patients evaluate the newly introduced system of substituting prescriptions?]

Catalog

Books, media, physical & digital resources